Cellexus Exhibiting at UK’s Top Investor Show
News Jun 14, 2006
Cellexus Biosystems PLC of Cambridgeshire, UK, will be exhibiting at the Growth Company Investor Show 2006, reported to be the biggest UK investment event, which takes place on Wednesday, June 21, at the Barbican in London.
The event is designed to showcase small- and mid-cap quoted companies to private and professional investors.
The Growth Company Investor Show provides an ideal opportunity for Cellexus Biosystems to profile themselves to existing investors and cultivate relationships with professional and expert private investors.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.